Biologic and Clinical Perspectives on Thyroid Cancer

By J. Fagin, S. Wells. New England Journal of Medicine, 2016

860 citations recorded by the source corpus.

As in many cancers, genetic analysis of thyroid cancers has identified subgroups that differ in their pathogenesis and has defined targets that make the cancer susceptible to particular therapies. Recent progress leading to new treatments is reviewed.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Oncology

View Paper: https://www.semanticscholar.org/paper/22ae26fe707ae12d109649e9375402ef3f6ae7bb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Mete
2. Zubair Baloch
3. M. Sobrinho-Simões
4. J. Barletta
5. G. Tallini
6. S. Asa
7. C. Jung
8. V. Livolsi

Citations in the corpus

• Overview of the 2022 WHO Classification of Thyroid Neoplasms (2022, background): “Therefore, the MAPK signaling output is lower, which could be a plausible explanation to the improved prognosis in RAS mutated tumors compared to BRAF-mutated cases [191].”